Development and application of novel imaging methods for observational studies and clinical trials
This group focuses on developing new imaging-based biomarkers for monitoring the early phases of neurodegenerative processes and, potentially, the response to disease-modifying treatments. We combine multiple modalities, including MRI, PET, fluid-based markers and genetics, to clarify the biological processes leading to neurodegenerative conditions. Additionally, we leverage data from deeply pheno
